カテゴリー： 世界, 医療/バイオ, Infiniti Research TechNavio

抗血栓薬の世界市場2023～2027

【英語タイトル】Global Antithrombotic Drugs Market 2023-2027

Technavioが出版した調査資料（IRTNTR75464-23）・商品コード：IRTNTR75464-23
・発行会社（調査会社）：Technavio
・発行日：2023年5月24日
・ページ数：約120
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後24時間以内）
・調査対象地域：グローバル
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥380,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD4,000 ⇒換算￥608,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

テクナビオ社の市場調査レポートでは、世界の抗血栓薬市場規模が2022年から2027年にかけて年平均8.42%成長し、23,199.94百万ドルに達すると予測しています。当レポートでは、抗血栓薬の世界市場について調査し、エグゼクティブサマリー、市場状況、市場規模・予測、過去市場規模、ファイブフォース分析、投与経路別（経口、注射）分析、流通チャネル別（病院薬局、小売薬局、オンライン薬局）、顧客状況、地域別状況（北米、ヨーロッパ、アジア太平洋、アメリカ、ドイツ、日本、カナダ、その他地域）、成長要因・課題・動向、企業状況、企業分析などの内容を掲載しています。なお、当市場の主要企業には、AbbVie Inc.、Aspen Pharmacare Holdings Ltd、AstraZeneca PLC、Bayer AG、Boehringer Ingelheim International GmbH、Bristol Myers Squibb Co.、Daiichi Sankyo Co. Ltd.、Eli Lilly and Co.、F. Hoffmann La Roche Ltd.、GlaxoSmithKline Plc、Hikma Pharmaceuticals Plc、Johnson and Johnson Services Inc.、Merck and Co. Inc.、Novartis AG、Otsuka Pharmaceutical Co. Ltd.、Pfizer Inc.、Sanofi SA、Teva Pharmaceutical Industries Ltd.、Viatris Inc.、Fresenius Kabi AGなどが含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模・予測
・過去市場規模
・ファイブフォース分析
・世界の抗血栓薬市場規模：投与経路別
　 - 経口投与の市場規模
　 - 注射投与の市場規模
・世界の抗血栓薬市場規模：流通チャネル別
　 - 病院薬局の市場規模
　 - 小売薬局の市場規模
　 - オンライン薬局の市場規模
・顧客状況
・地域別状況
　 - 北米の抗血栓薬市場規模
　 - ヨーロッパの抗血栓薬市場規模
　 - アジア太平洋の抗血栓薬市場規模
　 - アメリカの抗血栓薬市場規模
　 - ドイツの抗血栓薬市場規模
　 - 日本の抗血栓薬市場規模
　 - カナダの抗血栓薬市場規模
　 - その他地域の抗血栓薬市場規模
・成長要因・課題・動向
・企業状況
・企業分析

テクナビオ社は、利益・価格・競争・プロモーションなどの主要なパラメーターの分析から、複数のソースからのデータを研究、統合、総括の方法により、抗血栓薬市場の詳細なイメージを提示します。また、業界における主要インフルエンサーを特定することにより、市場の様々な側面を提供します。提示される情報は包括的​​で信頼性が高く、一次・二次の広範囲な調査結果です。 テクナビオ社の市場調査レポートは、正確な市場の成長を予測するために、完璧な競争環境と定性的・定量的調査手法を用いた詳細なベンダー選定方法と分析を提供します。

抗血栓薬の世界市場 2023-2027
抗血栓薬市場は2022〜2027年に23,199.94百万米ドルで成長し、予測期間中のCAGRは8.42%で加速すると予測されます。当レポートでは、抗血栓薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析も提供しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、凝固障害の有病率の増加、新規経口抗凝固薬の導入、強力な研究開発パイプラインの構築によって牽引されています。

Technavio社の抗血栓薬市場は以下のようにセグメント化されています：

・投与経路別：
– 経口剤
– 注射剤

・流通チャネル別：
– 病院薬局
– 小売薬局
– オンライン薬局

・地域別：
– 北米
– ヨーロッパ
– アジア
– その他の地域（ROW）

本調査では、今後数年間の抗血栓薬市場の成長を促進する主な要因の一つとして、抗凝固解毒剤の登場を挙げています。また、市場の焦点となる企業の戦略的提携や買収、市場の焦点となる新開発の成長は、市場の大きな需要につながるでしょう。

抗血栓薬市場に関するレポートは以下の分野をカバーしています：
– 抗血栓薬市場のサイジング
– 抗血栓薬市場の予測
– 抗血栓薬市場の産業分析

本レポートでは、抗血栓薬市場の主要ベンダーであるAbbVie Inc., Aspen Pharmacare Holdings Ltd, AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Otsuka Pharmaceutical Co. Ltd., Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Fresenius Kabi AGなどの企業情報が記載されています。また、抗血栓薬市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。当レポートでは、主要ベンダーの分析に加え、包括的な市場とベンダーの状況を掲載しています。

当出版社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約することによって、市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Route of Administration
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global antithrombotic drugs market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global antithrombotic drugs market 2017 – 2021 ($ million)
o 4.2 Route of Administration Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Route of Administration Segment 2017 – 2021 ($ million)
o 4.3 Distribution Channel Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Route of Administration
o 6.1 Market segments
o Exhibit 30: Chart on Route of Administration – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Route of Administration – Market share 2022-2027 (%)
o 6.2 Comparison by Route of Administration
o Exhibit 32: Chart on Comparison by Route of Administration
o Exhibit 33: Data Table on Comparison by Route of Administration
o 6.3 Oral – Market size and forecast 2022-2027
o Exhibit 34: Chart on Oral – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Oral – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Oral – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Oral – Year-over-year growth 2022-2027 (%)
o 6.4 Injectable – Market size and forecast 2022-2027
o Exhibit 38: Chart on Injectable – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Injectable – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Injectable – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Injectable – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Route of Administration
o Exhibit 42: Market opportunity by Route of Administration ($ million)
o Exhibit 43: Data Table on Market opportunity by Route of Administration ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 44: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 45: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 46: Chart on Comparison by Distribution Channel
o Exhibit 47: Data Table on Comparison by Distribution Channel
o 7.3 Hospital pharmacy – Market size and forecast 2022-2027
o Exhibit 48: Chart on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Hospital pharmacy – Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Hospital pharmacy – Year-over-year growth 2022-2027 (%)
o 7.4 Retail pharmacy – Market size and forecast 2022-2027
o Exhibit 52: Chart on Retail pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Retail pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Retail pharmacy – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Retail pharmacy – Year-over-year growth 2022-2027 (%)
o 7.5 Online pharmacy – Market size and forecast 2022-2027
o Exhibit 56: Chart on Online pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Online pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Online pharmacy – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Online pharmacy – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 60: Market opportunity by Distribution Channel ($ million)
o Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 67: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 83: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 87: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 UK – Market size and forecast 2022-2027
o Exhibit 91: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.10 Japan – Market size and forecast 2022-2027
o Exhibit 95: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.11 Canada – Market size and forecast 2022-2027
o Exhibit 99: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Aspen Pharmacare Holdings Ltd
o Exhibit 111: Aspen Pharmacare Holdings Ltd – Overview
o Exhibit 112: Aspen Pharmacare Holdings Ltd – Business segments
o Exhibit 113: Aspen Pharmacare Holdings Ltd – Key offerings
o Exhibit 114: Aspen Pharmacare Holdings Ltd – Segment focus
o 12.4 AstraZeneca PLC
o Exhibit 115: AstraZeneca PLC – Overview
o Exhibit 116: AstraZeneca PLC – Product / Service
o Exhibit 117: AstraZeneca PLC – Key news
o Exhibit 118: AstraZeneca PLC – Key offerings
o 12.5 Bayer AG
o Exhibit 119: Bayer AG – Overview
o Exhibit 120: Bayer AG – Business segments
o Exhibit 121: Bayer AG – Key news
o Exhibit 122: Bayer AG – Key offerings
o Exhibit 123: Bayer AG – Segment focus
o 12.6 Boehringer Ingelheim International GmbH
o Exhibit 124: Boehringer Ingelheim International GmbH – Overview
o Exhibit 125: Boehringer Ingelheim International GmbH – Business segments
o Exhibit 126: Boehringer Ingelheim International GmbH – Key news
o Exhibit 127: Boehringer Ingelheim International GmbH – Key offerings
o Exhibit 128: Boehringer Ingelheim International GmbH – Segment focus
o 12.7 Bristol Myers Squibb Co.
o Exhibit 129: Bristol Myers Squibb Co. – Overview
o Exhibit 130: Bristol Myers Squibb Co. – Product / Service
o Exhibit 131: Bristol Myers Squibb Co. – Key news
o Exhibit 132: Bristol Myers Squibb Co. – Key offerings
o 12.8 Daiichi Sankyo Co. Ltd.
o Exhibit 133: Daiichi Sankyo Co. Ltd. – Overview
o Exhibit 134: Daiichi Sankyo Co. Ltd. – Product / Service
o Exhibit 135: Daiichi Sankyo Co. Ltd. – Key news
o Exhibit 136: Daiichi Sankyo Co. Ltd. – Key offerings
o 12.9 Eli Lilly and Co.
o Exhibit 137: Eli Lilly and Co. – Overview
o Exhibit 138: Eli Lilly and Co. – Product / Service
o Exhibit 139: Eli Lilly and Co. – Key news
o Exhibit 140: Eli Lilly and Co. – Key offerings
o 12.10 F. Hoffmann La Roche Ltd.
o Exhibit 141: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 142: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 143: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 144: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 145: F. Hoffmann La Roche Ltd. – Segment focus
o 12.11 Fresenius Kabi AG
o Exhibit 146: Fresenius Kabi AG – Overview
o Exhibit 147: Fresenius Kabi AG – Business segments
o Exhibit 148: Fresenius Kabi AG – Key news
o Exhibit 149: Fresenius Kabi AG – Key offerings
o Exhibit 150: Fresenius Kabi AG – Segment focus
o 12.12 Hikma Pharmaceuticals Plc
o Exhibit 151: Hikma Pharmaceuticals Plc – Overview
o Exhibit 152: Hikma Pharmaceuticals Plc – Business segments
o Exhibit 153: Hikma Pharmaceuticals Plc – Key offerings
o Exhibit 154: Hikma Pharmaceuticals Plc – Segment focus
o 12.13 Novartis AG
o Exhibit 155: Novartis AG – Overview
o Exhibit 156: Novartis AG – Business segments
o Exhibit 157: Novartis AG – Key offerings
o Exhibit 158: Novartis AG – Segment focus
o 12.14 Otsuka Pharmaceutical Co. Ltd.
o Exhibit 159: Otsuka Pharmaceutical Co. Ltd. – Overview
o Exhibit 160: Otsuka Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 161: Otsuka Pharmaceutical Co. Ltd. – Key offerings
o 12.15 Sanofi SA
o Exhibit 162: Sanofi SA – Overview
o Exhibit 163: Sanofi SA – Business segments
o Exhibit 164: Sanofi SA – Key news
o Exhibit 165: Sanofi SA – Key offerings
o Exhibit 166: Sanofi SA – Segment focus
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 167: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 168: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 169: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 170: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 171: Teva Pharmaceutical Industries Ltd. – Segment focus
o 12.17 Viatris Inc.
o Exhibit 172: Viatris Inc. – Overview
o Exhibit 173: Viatris Inc. – Business segments
o Exhibit 174: Viatris Inc. – Key news
o Exhibit 175: Viatris Inc. – Key offerings
o Exhibit 176: Viatris Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 177: Inclusions checklist
o Exhibit 178: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 179: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 180: Research methodology
o Exhibit 181: Validation techniques employed for market sizing
o Exhibit 182: Information sources
o 13.5 List of abbreviations
o Exhibit 183: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global antithrombotic drugs market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Route of Administration Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Route of Administration – Market share 2022-2027 (%)
Exhibits31: Data Table on Route of Administration – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Route of Administration
Exhibits33: Data Table on Comparison by Route of Administration
Exhibits34: Chart on Oral – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Oral – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Oral – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Oral – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Injectable – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Injectable – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Injectable – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Injectable – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Route of Administration ($ million)
Exhibits43: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits44: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits45: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Distribution Channel
Exhibits47: Data Table on Comparison by Distribution Channel
Exhibits48: Chart on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Hospital pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Hospital pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Retail pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Retail pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Retail pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Retail pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Online pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Online pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Online pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Online pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Distribution Channel ($ million)
Exhibits61: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Aspen Pharmacare Holdings Ltd – Overview
Exhibits112: Aspen Pharmacare Holdings Ltd – Business segments
Exhibits113: Aspen Pharmacare Holdings Ltd – Key offerings
Exhibits114: Aspen Pharmacare Holdings Ltd – Segment focus
Exhibits115: AstraZeneca PLC – Overview
Exhibits116: AstraZeneca PLC – Product / Service
Exhibits117: AstraZeneca PLC – Key news
Exhibits118: AstraZeneca PLC – Key offerings
Exhibits119: Bayer AG – Overview
Exhibits120: Bayer AG – Business segments
Exhibits121: Bayer AG – Key news
Exhibits122: Bayer AG – Key offerings
Exhibits123: Bayer AG – Segment focus
Exhibits124: Boehringer Ingelheim International GmbH – Overview
Exhibits125: Boehringer Ingelheim International GmbH – Business segments
Exhibits126: Boehringer Ingelheim International GmbH – Key news
Exhibits127: Boehringer Ingelheim International GmbH – Key offerings
Exhibits128: Boehringer Ingelheim International GmbH – Segment focus
Exhibits129: Bristol Myers Squibb Co. – Overview
Exhibits130: Bristol Myers Squibb Co. – Product / Service
Exhibits131: Bristol Myers Squibb Co. – Key news
Exhibits132: Bristol Myers Squibb Co. – Key offerings
Exhibits133: Daiichi Sankyo Co. Ltd. – Overview
Exhibits134: Daiichi Sankyo Co. Ltd. – Product / Service
Exhibits135: Daiichi Sankyo Co. Ltd. – Key news
Exhibits136: Daiichi Sankyo Co. Ltd. – Key offerings
Exhibits137: Eli Lilly and Co. – Overview
Exhibits138: Eli Lilly and Co. – Product / Service
Exhibits139: Eli Lilly and Co. – Key news
Exhibits140: Eli Lilly and Co. – Key offerings
Exhibits141: F. Hoffmann La Roche Ltd. – Overview
Exhibits142: F. Hoffmann La Roche Ltd. – Business segments
Exhibits143: F. Hoffmann La Roche Ltd. – Key news
Exhibits144: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits145: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits146: Fresenius Kabi AG – Overview
Exhibits147: Fresenius Kabi AG – Business segments
Exhibits148: Fresenius Kabi AG – Key news
Exhibits149: Fresenius Kabi AG – Key offerings
Exhibits150: Fresenius Kabi AG – Segment focus
Exhibits151: Hikma Pharmaceuticals Plc – Overview
Exhibits152: Hikma Pharmaceuticals Plc – Business segments
Exhibits153: Hikma Pharmaceuticals Plc – Key offerings
Exhibits154: Hikma Pharmaceuticals Plc – Segment focus
Exhibits155: Novartis AG – Overview
Exhibits156: Novartis AG – Business segments
Exhibits157: Novartis AG – Key offerings
Exhibits158: Novartis AG – Segment focus
Exhibits159: Otsuka Pharmaceutical Co. Ltd. – Overview
Exhibits160: Otsuka Pharmaceutical Co. Ltd. – Product / Service
Exhibits161: Otsuka Pharmaceutical Co. Ltd. – Key offerings
Exhibits162: Sanofi SA – Overview
Exhibits163: Sanofi SA – Business segments
Exhibits164: Sanofi SA – Key news
Exhibits165: Sanofi SA – Key offerings
Exhibits166: Sanofi SA – Segment focus
Exhibits167: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits168: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits169: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits170: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits171: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits172: Viatris Inc. – Overview
Exhibits173: Viatris Inc. – Business segments
Exhibits174: Viatris Inc. – Key news
Exhibits175: Viatris Inc. – Key offerings
Exhibits176: Viatris Inc. – Segment focus
Exhibits177: Inclusions checklist
Exhibits178: Exclusions checklist
Exhibits179: Currency conversion rates for US$
Exhibits180: Research methodology
Exhibits181: Validation techniques employed for market sizing
Exhibits182: Information sources
Exhibits183: List of abbreviations



★調査レポート[抗血栓薬の世界市場2023～2027] (コード：IRTNTR75464-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[抗血栓薬の世界市場2023～2027]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の調剤薬局市場2023-2027
  • 開放隅角緑内障治療薬のグローバル市場2023-2027：病院薬局、小売薬局、オンライン薬局
  • 非ホジキンリンパ腫治療のグローバル市場2023-2027：病院薬局、小売薬局、オンライン薬局、その他
  • びまん性大細胞型B細胞リンパ腫（DLBCL）治療薬のグローバル市場2023～2027：病院薬局、小売薬局、オンライン薬局、その他
  • 世界の自閉スペクトラム症（ASD）治療薬市場2023-2027
  • 網膜治療薬のグローバル市場2023-2027：病院薬局、小売薬局、オンライン薬局
  • 静脈内IV溶液のグローバル市場2023～2027：末梢静脈栄養、中心静脈栄養
  • 世界の自律型水中探査機（AUV）市場2023-2027
  • 自己免疫薬のグローバル市場2023～2027：関節リウマチ、多発性硬化症、乾癬、炎症性腸疾患、その他
  • 携帯式浄水器のグローバル市場2023-2027：野外活動、観光・レジャー、軍事、緊急救助、その他

    • ◆H&Iグローバルリサーチのお客様（例）◆